Achieving Health in Emerging Adults With Diabetes (AHEAD) Program: A Clinical Trial Designed to Understand if Participation in a Clinical Program Developed Specifically to Support Emerging Adults With Type 1 Diabetes Leads to Improved Diabetes Outcomes.

Part of paid clinical trials in Seattle, Washington.

Sponsor
University of British Columbia
Study ID
NCT07292558
Status
Recruiting
Apply to this trial

Conditions

  • Diabetes Mellitus, Type 1 Diabetes

Eligibility Criteria

Sex
ALL
Age
16 Years - 19 Years
Healthy Volunteers
Not accepted

Interventions

  • AHEAD Program — BEHAVIORAL
    Participants will complete self-assessments around health care transition readiness and mental health prior to an AHEAD clinic visit. Emerging adults will then received tailored clinical support based on their self-assessments and work to build their autonomy and competence to manage their diabetes and health care independently with the support of their AHEAD providers.

Study Details

The goal of this study is to determine whether the Achieving Health in Emerging Adults with Diabetes (AHEAD) Program helps emerging adults with type 1 diabetes improve their blood glucose management during the transition from pediatric to adult care. Participants will be randomized to receive Usual Care or the AHEAD Program, which provides tailored support to emerging adults to build autonomy and competence to facilitate independent diabetes management. Researchers will compare changes in glycemia and participant-reported outcomes between groups.

Key Dates

Start date
Dec 15, 2025
Status verified
Dec 2025
Primary completion
Dec 31, 2028
Completion
Dec 31, 2028

Study Design

Enrollment
306 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT

Arms

  • Experimental: AHEAD Program
    AHEAD participants will receive support from a team of diabetes providers with expertise in supporting older adolescents and young adults who will work to build autonomy and competence needed to manage diabetes independently.
  • No Intervention: Usual Care
    Usual Care participants will receive diabetes care as currently being provided by their primary medical team.

Primary Outcome Measure

Hemoglobin A1c (HbA1c) [ Time Frame: From enrollment (baseline clinic visit: 0 months) to the end of intervention period (6th clinic visit: 15-24 months). ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Seattle Children'sSeattleWashington98101
Beth Loots, MPH, MSW
[email protected]
206-884-4488
Tian Westland, BS
[email protected]
206-884-2528
Catherine Pihoker, MD (PRINCIPAL_INVESTIGATOR)

Find similar trials in Seattle, WA

By research site
Seattle Children's· Seattle, WA

Related Studies